Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Investing.com -- Shares of Clearwater Paper Corp . (NYSE:CLW) surged 15% following reports that Brazil's Suzano SA is considering a takeover bid for the company. According to Bloomberg, Suzano is ...

Investing.com -- TD Cowen analysts upgraded BlackBerry (NYSE:BB) shares on Friday after the cybersecurity software firm delivered solid financial results for the fiscal third quarter a day earlier.

Investing.com -- US stock futures fell Friday as the threat of a US government shutdown increased, and as investors awaited the release of key inflation data. Here are some of the biggest premarket US ...

Investing.com -- Shares of Occidental Petroleum (NYSE:OXY), Sirius XM Holdings (NASDAQ:SIRI), and VeriSign (NASDAQ:VRSN) saw an uptick in the trading session following news of Berkshire Hathaway (NYSE ...

Investing.com -- Aadi Bioscience, Inc. (NASDAQ:AADI) shares surged 24% in pre-open trading Friday following the company's announcement of a strategic licensing agreement and a significant asset sale.

Investing.com -- President-elect Donald Trump warned that the European Union (EU) must significantly increase its purchases of American oil and gas or face tariffs on European imports. “I told the ...

Investing.com -- Ionis Pharmaceuticals (NASDAQ:IONS) shares climbed 6% in pre-open trading Friday after announcing the U.S. Food and Drug Administration (FDA) approval of TRYNGOLZA™ (olezarsen) for ...

Investing.com -- Bitcoin's value plummeted approximately 9% on Friday, as the cryptocurrency market experienced a sharp sell-off, possibly reflecting a broader investor retreat from risk assets. The ...

Investing.com -- Former Nissan (OTC:NSANY) Motor Co. chairman, Carlos Ghosn, has commented on the potential deal between Nissan and Honda Motor Co (NYSE:HMC)., labeling it a "desperate move". Ghosn ...

Investing.com -- Shares of Novo Nordisk (NYSE:NVO) A/S, the Danish pharmaceutical company, experienced a significant drop following the release of less than anticipated results from a study of its ...

Investing.com -- Shares of Novo Nordisk (NYSE:NVO) plummeted over 19% in premarket trading Friday after the results from its phase 3 trial of CagriSema, its next-generation obesity drug, disappointed.